Improvements in persistence and compliance with various bisphosphonates with long-term patient education using FRAX

Improvements in persistence and compliance with various bisphosphonates with long-term patient education using FRAX - IMPROVABLE trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001628

Enrollment

200

Registered

2009-01-13

Start date

2009-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteoporosis

Interventions

Patients with osteoporosis who are going to receive bisphosphonates are randomly assigned to 2 study groups. Group A receive patient education with information about 10-year fracture probability using

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients aged 40 years or older, with a prior or new diagnosis of osteoporosis and receiving treatment with bisphosphonates.

Exclusion criteria

Exclusion criteria: patients who are inappropriate to receive bisphosphonates

Design outcomes

Primary

Measure	Time frame
persistence with bisphosphonate therapy	—

Secondary

Measure	Time frame
compliance with bisphosphonate therapy change in bone mineral density	—

Countries

Japan

Contacts

Public ContactShigeru Ohno

Yokohama City University Medical Center Center for rheumatic diseases

ohno@urahp.yokohama-cu.ac.jp045-261-5656

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026